Vanguard Fiduciary Trust
MIRA icon

Vanguard Fiduciary Trust’s MIRA Pharmaceuticals MIRA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162K Buy
170,668
+1,185
+0.7% +$1.2K ﹤0.01% 3636
2026
Q1 		$181K Buy
+169,483
New +$212K ﹤0.01% 3545

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Vanguard Fiduciary Trust's MIRA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its MIRA Pharmaceuticals (MIRA) stake by 0.7% in Q2 2026, buying an estimated $1.2K and bringing the position to 170,668 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.

Vanguard Fiduciary Trust first reported a position in MIRA in Q1 2026 and has held it in 2 quarters since. The position peaked at $181K in Q1 2026. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Vanguard Fiduciary Trust held 170,668 shares of MIRA Pharmaceuticals worth $162K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 1,185 MIRA Pharmaceuticals shares in Q2 2026, an estimated $1.2K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3636 holding.
  • Vanguard Fiduciary Trust first reported a position in MIRA Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's MIRA Pharmaceuticals position peaked at $181K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.